Clinical trial NCT00573183: Stimulant Abuser Groups to Engage in 12-Step
Official title: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Drug Abuse
Keywords: Cocaine, methamphetamine, amphetamine, other stimulant drugs
Lead sponsor: University of Washington
Sponsor class: OTHER
Collaborators: name: National Institute on Drug Abuse (NIDA)
First posted: 2007-12-14
Enrollment: 471
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.

Detailed description: This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.

Eligibility criteria: Inclusion Criteria:

* seeking outpatient treatment for stimulant abuse or dependence
* current diagnosis of stimulant abuse or dependence
* willing to participate in the protocol

Exclusion Criteria:

* not sufficiently medically or psychiatrically stable
* pending legal action that would inhibit their participation in the study
* in need of detoxification from opiates

Primary outcomes:
measure: Days of Stimulant Use
timeFrame: 6 months
Secondary outcomes:
measure: Attendance at 12-step Meetings
timeFrame: 6 months
Other outcomes:
Locations:
city: Jacksonville
country: United States
facility: Gateway Community Services
state: Florida
city: Kaneohe
country: United States
facility: Hina Mauka Kaneohe Rehabilitation Services
state: Hawaii
city: Columbus
country: United States
facility: Maryhaven, Inc.
state: Ohio
city: Eugene
country: United States
facility: Willamette Family Treatment Services
state: Oregon
city: Portland
country: United States
facility: ChangePoint, Inc.
state: Oregon
city: Pittsburgh
country: United States
facility: Addiction Medicine Services (WPIC)
state: Pennsylvania
city: Summerville
country: United States
facility: Dorchester Alcohol and Drug Commission
state: South Carolina
city: Dallas
country: United States
facility: Nexus Recovery Center
state: Texas
city: Everett
country: United States
facility: Evergreen Manor, Inc.
state: Washington
city: Seattle
country: United States
facility: Recovery Centers of King County
state: Washington
Study officials:
affiliation: University of Washington
name: Dennis Donovan, Ph.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: Western Psychiatric Institute and Clinic
name: Dennis Daley, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
citation: Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Seamans C, Zammarelli L. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan;44(1):103-14. doi: 10.1016/j.jsat.2012.04.004. Epub 2012 May 31.